[
  {
    "ts": null,
    "headline": "ResMed Inc. (RMD) Q1 2026 Earnings Call Transcript",
    "summary": "ResMed Inc. (RMD) Q1 2026 Earnings Call October 30, 2025 4:30 PM EDTCompany ParticipantsSallilyn Schwartz - Chief Investor Relations OfficerMichael Farrell...",
    "url": "https://finnhub.io/api/news?id=9592743cd343a7c92b9cc915dba44ddd1e30eccaf8832d77f1b9bf0a877d21a8",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761862586,
      "headline": "ResMed Inc. (RMD) Q1 2026 Earnings Call Transcript",
      "id": 137273435,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "RMD",
      "source": "SeekingAlpha",
      "summary": "ResMed Inc. (RMD) Q1 2026 Earnings Call October 30, 2025 4:30 PM EDTCompany ParticipantsSallilyn Schwartz - Chief Investor Relations OfficerMichael Farrell...",
      "url": "https://finnhub.io/api/news?id=9592743cd343a7c92b9cc915dba44ddd1e30eccaf8832d77f1b9bf0a877d21a8"
    }
  },
  {
    "ts": null,
    "headline": "Compared to Estimates, ResMed (RMD) Q1 Earnings: A Look at Key Metrics",
    "summary": "While the top- and bottom-line numbers for ResMed (RMD) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.",
    "url": "https://finnhub.io/api/news?id=9093f2c1195cefb9ba253e6b5622c9e79ff73d0d440c2c2d64ee87dd2166f2ad",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761859802,
      "headline": "Compared to Estimates, ResMed (RMD) Q1 Earnings: A Look at Key Metrics",
      "id": 137275356,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "While the top- and bottom-line numbers for ResMed (RMD) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.",
      "url": "https://finnhub.io/api/news?id=9093f2c1195cefb9ba253e6b5622c9e79ff73d0d440c2c2d64ee87dd2166f2ad"
    }
  },
  {
    "ts": null,
    "headline": "ResMed (RMD) Q1 Earnings and Revenues Beat Estimates",
    "summary": "ResMed (RMD) delivered earnings and revenue surprises of +2.41% and +0.94%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?",
    "url": "https://finnhub.io/api/news?id=48f999c80aae8b0692a10bb7ace87086fe6dfa42bdcc358caeb9a59570621c49",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761858903,
      "headline": "ResMed (RMD) Q1 Earnings and Revenues Beat Estimates",
      "id": 137275357,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "ResMed (RMD) delivered earnings and revenue surprises of +2.41% and +0.94%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?",
      "url": "https://finnhub.io/api/news?id=48f999c80aae8b0692a10bb7ace87086fe6dfa42bdcc358caeb9a59570621c49"
    }
  },
  {
    "ts": null,
    "headline": "ResMed: Fiscal Q1 Earnings Snapshot",
    "summary": "SAN DIEGO (AP) — ResMed Inc. RMD) on Thursday reported fiscal first-quarter net income of $348.5 million. On a per-share basis, the San Diego-based company said it had net income of $2.37.",
    "url": "https://finnhub.io/api/news?id=3fd5105af998ffc6eb96d7a936d441cd103c61843794bc27ea957040b036525a",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761855449,
      "headline": "ResMed: Fiscal Q1 Earnings Snapshot",
      "id": 137269556,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "SAN DIEGO (AP) — ResMed Inc. RMD) on Thursday reported fiscal first-quarter net income of $348.5 million. On a per-share basis, the San Diego-based company said it had net income of $2.37.",
      "url": "https://finnhub.io/api/news?id=3fd5105af998ffc6eb96d7a936d441cd103c61843794bc27ea957040b036525a"
    }
  },
  {
    "ts": null,
    "headline": "ResMed (NYSE:RMD) Reports Q3 In Line With Expectations",
    "summary": "Medical device company ResMed (NYSE:RMD) met Wall Streets revenue expectations in Q3 CY2025, with sales up 9.1% year on year to $1.34 billion. Its non-GAAP profit of $2.55 per share was 2.1% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=8df5ca4c571f68420d8201f5793d8ff82de9c1334c422f21b7cfaff1b6e34703",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761855309,
      "headline": "ResMed (NYSE:RMD) Reports Q3 In Line With Expectations",
      "id": 137275358,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Medical device company ResMed (NYSE:RMD) met Wall Streets revenue expectations in Q3 CY2025, with sales up 9.1% year on year to $1.34 billion. Its non-GAAP profit of $2.55 per share was 2.1% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=8df5ca4c571f68420d8201f5793d8ff82de9c1334c422f21b7cfaff1b6e34703"
    }
  },
  {
    "ts": null,
    "headline": "Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2026",
    "summary": "Revenue increased by 9% to $1.3 billion; up 8% on a constant currency basis Gross margin up 290 bps to 61.5%; non-GAAP gross margin up 280 bps to 62.0%Income from operations increased 15%; non-GAAP income from operations up 19%Diluted earnings per share of $2.37; non-GAAP diluted earnings per share of $2.55Operating cash flow of $457 million Note: A webcast of Resmed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Oct. 30, 2025 (GLOBE NEWSWIRE)",
    "url": "https://finnhub.io/api/news?id=2bfbfde7dcbbe9e6536074a30cefd7c336683eca856bf3ee368d32298f9bb895",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761854700,
      "headline": "Resmed Inc. Announces Results for the First Quarter of Fiscal Year 2026",
      "id": 137269557,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "RMD",
      "source": "Yahoo",
      "summary": "Revenue increased by 9% to $1.3 billion; up 8% on a constant currency basis Gross margin up 290 bps to 61.5%; non-GAAP gross margin up 280 bps to 62.0%Income from operations increased 15%; non-GAAP income from operations up 19%Diluted earnings per share of $2.37; non-GAAP diluted earnings per share of $2.55Operating cash flow of $457 million Note: A webcast of Resmed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com SAN DIEGO, Oct. 30, 2025 (GLOBE NEWSWIRE)",
      "url": "https://finnhub.io/api/news?id=2bfbfde7dcbbe9e6536074a30cefd7c336683eca856bf3ee368d32298f9bb895"
    }
  }
]